To date, attempts have been made to target stemness markers, such as STAT3 and NANOG [6], as well as pathways that regulate malignant stemness, most notably the Wnt/β-catenin, Notch, hedgehog, and JAK-STAT pathways, which promote stemness features in various cancers [26]. This evidence concerns the gene STAT3 and cancer.